Related Experiment Video
Updated: May 5, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Structure of MurNAc 6-phosphate hydrolase (MurQ) from Haemophilus influenzae with a bound inhibitor
Timin Hadi1, Saugata Hazra, Martin E Tanner
1Department of Biochemistry, Albert Einstein College of Medicine , 1300 Morris Park Avenue, Bronx, New York 10461, United States.
Abstract:
The breakdown and recycling of peptidoglycan, an essential polymeric cell structure, occur in a number of bacterial species. A key enzyme in the recycling pathway of one of the components of the peptidoglycan layer, N-acetylmuramic acid (MurNAc), is MurNAc 6-phosphate hydrolase (MurQ). This enzyme catalyzes the cofactor-independent cleavage of a relatively nonlabile ether bond and presents an interesting target for mechanistic studies. Open chain product and substrate analogues were synthesized and tested as competitive inhibitors (K(is) values of 1.1 ± 0.3 and 0.23 ± 0.02 mM, respectively) of the MurNAc 6P hydrolase from Escherichia coli (MurQ-EC). To identify the roles of active site residues that are important for catalysis, the substrate analogue was cocrystallized with the MurNAc 6P hydrolase from Haemophilus influenzae (MurQ-HI) that was amenable to crystallographic studies. The cocrystal structure of MurQ-HI with the substrate analogue showed that Glu89 was located in the proximity of both the C2 atom and the oxygen at the C3 position of the bound inhibitor and that no other potential acid/base residue that could act as an active site acid/base was located in the vicinity. The conserved residues Glu120 and Lys239 were found within hydrogen bonding distance of the C5 hydroxyl group and C6 phosphate group, suggesting that they play a role in substrate binding and ring opening. Combining these results with previous biochemical data, we propose a one-base mechanism of action in which Glu89 functions to both deprotonate at the C2 position and assist in the departure of the lactyl ether at the C3 position. This same residue would serve to deprotonate the incoming water and reprotonate the enolate in the second half of the catalytic cycle.
Insights
MurNAc 6-phosphate hydrolase (MurQ) recycles peptidoglycan components. Structural and biochemical studies reveal a one-base catalytic mechanism involving Glu89 for N-acetylmuramic acid recycling.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Peptidoglycan is a vital bacterial cell wall component.
- N-acetylmuramic acid (MurNAc) is a key peptidoglycan subunit.
- MurNAc 6-phosphate hydrolase (MurQ) is crucial for MurNAc recycling.
Purpose of the Study:
- To elucidate the catalytic mechanism of MurNAc 6-phosphate hydrolase (MurQ).
- To identify key active site residues involved in MurQ catalysis.
- To investigate MurQ as a potential target for mechanistic studies.
Main Methods:
- Synthesis and testing of competitive inhibitors for MurQ.
- Cocrystallization of MurNAc 6-phosphate hydrolase from Haemophilus influenzae (MurQ-HI) with a substrate analogue.
- X-ray crystallography to determine the cocrystal structure.
- Analysis of active site residue interactions.
Main Results:
- Substrate and product analogues exhibited competitive inhibition of MurQ-EC.
- Cocrystal structure revealed Glu89 proximity to inhibitor C2 and C3-oxygen.
- Conserved residues Glu120 and Lys239 are involved in substrate binding and ring opening.
- Identified Glu89 as a potential catalytic residue.
Conclusions:
- Proposed a one-base catalytic mechanism for MurQ.
- Glu89 acts as the catalytic base, facilitating deprotonation and ether cleavage.
- The mechanism involves Glu89 in both halves of the catalytic cycle, including water activation.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Enzyme Inhibition

